Return on Investment of patent assets
80% of a company’s assets are now intangible. Without the help of robust models like ROI, how can you calculate the value of those assets and plan accordingly?
23rd April 2021
Diagnostics and Drug Development: Is Artificial Intelligence conquering other sectors?
The Artificial Intelligence (AI) wave is sweeping the world and taking over one industry at a time. It is everywhere around us – from suggesting what to view or buy, categorising our photos/emails, even figuring out the fastest route to reach our destination. With the many applications of AI, you can see an increase of applications within the healthcare sector. This can range from accessing medical care virtually to the production of new drug treatments which can then be made more readily available for us.
This report looks at the organisations and technologies dominating this patent landscape and have spotted some interesting trends. We have looked at three key technology areas representing AI in Diagnostics and Drug Development:
- Drug Development
- Medical Imaging
- Diagnostic and Treatment
But who owns these technologies and is dominating this innovative space?
Source: Cipher
Fill out the form below to gain access to our report on Diagnostics and Drug Development: Is Artificial Intelligence conquering other sectors? and discover the latest trends emerging in this patent landscape and how the major tech companies are dominating this space.
Download Diagnostics and Drug Development report
Diagnostics and Drug Development
Key takeaways of the report include:
-
Tech Giants are the major innovators in AI for Diagnostics and Drug Development, rather than Pharma
-
Medical Imaging is the largest area in AI for Diagnostics and Drug Development
-
China is leading the way in development of innovation in this space
Diagnostics and Drug Development
With Cipher you can...
Optimise your portfolio
Ensure you have the right portfolio to meet your strategic patenting objectives.
Gather competitor intelligence
Understand who’s doing what by automating patent to technology mapping.
Model cross licensing
Combine patent and revenue data to determine rational licensing outcomes.
Manage your budget
Justify patent budgets to CFOs and others to communicate the impact of your investment.
Conduct due diligence
Automate manual reviews for efficient execution of M&A and licensing transactions.
Tackle inbound patent assertion
Be prepared with evidence to create a fast and effective threat assessment.
Benchmark your portfolio
Assess your portfolio in comparison to other owners through your technology lens.
Monetise your portfolio
Identify opportunities to create value through licensing or sale of patent assets.
Predict technology trends
Track new technologies of today and discover the unknown owners of future disruptive innovation.